bluebird bio to present LentiGlobin® BB305 Clinical Data and bb2121 Preclinical Data at Annual Meeting of the American Society of Hematology Read more about bluebird bio to present LentiGlobin® BB305 Clinical Data and bb2121 Preclinical Data at Annual Meeting of the American Society of Hematology
bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress Read more about bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress
bluebird bio Announces Participation in 24th Annual Credit Suisse Healthcare Conference Read more about bluebird bio Announces Participation in 24th Annual Credit Suisse Healthcare Conference
bluebird bio Announces Presentation at Cooley’s Anemia Foundation Symposium Read more about bluebird bio Announces Presentation at Cooley’s Anemia Foundation Symposium
bluebird bio Announces Participation in Leerink Partners Immuno-Oncology Roundtable Read more about bluebird bio Announces Participation in Leerink Partners Immuno-Oncology Roundtable
bluebird bio Announces Participation at Morgan Stanley Global Healthcare Conference Read more about bluebird bio Announces Participation at Morgan Stanley Global Healthcare Conference
bluebird bio Reports Second Quarter 2015 Financial Results and Recent Operational Progress Read more about bluebird bio Reports Second Quarter 2015 Financial Results and Recent Operational Progress
bluebird bio Announces Participation at the 2015 Wedbush PacGrow Healthcare Conference Read more about bluebird bio Announces Participation at the 2015 Wedbush PacGrow Healthcare Conference
bluebird bio Announces Pricing of Public Offering of Common Stock Read more about bluebird bio Announces Pricing of Public Offering of Common Stock
bluebird bio Announces Proposed Public Offering of Common Stock Read more about bluebird bio Announces Proposed Public Offering of Common Stock